Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
Rituxan articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
Seattle Genetics Presents ADCETRIS® (Brentuximab ...
... evaluate ADCETRIS in CD30-positive disease, CD30-undetectable disease and in combination with
(rituximab). Data were reported from 51 patients with CD30-undetectable DLBCL using standard...
Read more at
+ 12 more articles
American Society of Hematology
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.